Abstract:An efficient radiotherapeutic agent is synthesized using ultrathin two-dimensional 30-nm-wide and 2-nm-thick Bi2Se3 nanosheets (NSs) as a radiosensitizer. Chitosan (CS) and RGD peptide are employed to enhance the radiotherapy efficiency and biocompatibility. The Bi2Se3-CS-RGD NSs exhibit excellent targeting ability to αvβ3 integrin-overexpressing cancer cells and potent radiosensitization efficiency with high stability. Detailed in vitro experiments show that the Bi2Se3-CS-RGD NSs enhance the sensitivity of HeLa cells to X-ray-induced cell death by inhibiting TrxR activities and activating downstream reactive oxygen species-mediated signaling pathways. In vivo experiments using intravenous or intratumor injection demonstrate that the Bi2Se3-CS-RGD NSs are more efficient tumor growth inhibitors compared to bare Bi2Se3 NSs. The multifunctionality of the NSs enables the use of photoacoustic imaging and magnetic resonance imaging to examine their targeting ability and therapeutic effects, respectively. In addition, the RGD-decorated Bi2Se3 NSs show much better in vivo biocompatibility and can be efficiently expelled from the body after 48 h post injection. This study reveals an effective and safe theranostic agent for next-generation cancer radiotherapy. A nanomaterial that enhances the targeted destruction of cancer cells by radiotherapy has been demonstrated by scientists in China. Radiotherapy uses X-rays to destroy cancerous cells, but some cancers are not sensitive to X-rays. Injecting an agent into the body that binds to cancer cells can make them more sensitive, but it is difficult to make such agents on large scales. Tianfeng Chen from Jinan University in Guangzhou and co-workers combined two-dimensional sheets of bismuth selenide with chitosan and a peptide to create a biocompatible material that enhances radiotherapy efficiency. The material shows excellent ability to target cancer cells and has a potent radiosensitization efficiency with high stability. Furthermore, it has good biocompatibility and is efficiently expelled from the body efficiently after injection. Ultrathin Bi2Se3-CS-RGD NSs with excellent tumor-targeting ability and potent radiosensitization efficiency are constructed for imaging-guided cancer radiotherapy. The NSs in combination with X-ray irradiation inhibit HeLa cell growth by inducing G0/G1 cycle arrest and mitochondria-mediated intrinsic cell apoptosis, inhibiting TrxR and activating downstream ROS-mediated signaling pathways. Moreover, RGD coating enables the NSs to aggregate in the tumor regions quickly enabling efficient PAI of the entire tumor to facilitate radiotherapy of cervical cancer. Taken together, this study provides an effective and safe theranostic agent for next-generation cancer radiotherapy.

Ultrasmall Biocompatible Bi2Se3 Nanodots for Multimodal Imaging-Guided Synergistic Radiophotothermal Therapy Against Cancer.

Albumin-Assisted Synthesis of Ultrasmall FeS2 Nanodots for Imaging-Guided Photothermal Enhanced Photodynamic Therapy.

Untrasmall Bi2s3 Nanodots for in Vivo X-Ray Ct Imaging-Guided Photothermal Therapy of Cancer

Ultrasmall Biocompatible Wo3-X Nanodots for Multi-Modality Imaging and Combined Therapy of Cancers

Ultrasmall AgBiSe2 Nanodots for CT/Thermal-imaging Guided Photothermal Tumor Therapy in NIR-II Biowindow

Ultrasmall PEI-Decorated Bi2Se3 Nanodots As a Multifunctional Theranostic Nanoplatform for in Vivo CT Imaging-Guided Cancer Photothermal Therapy

Multimodal Imaging-Guided Antitumor Photothermal Therapy and Drug Delivery Using Bismuth Selenide Spherical-Sponge.

Fese2-Decorated Bi2se3 Nanosheets Fabricated Via Cation Exchange For Chelator-Free Cu-64-Labeling And Multimodal Image-Guided Photothermal-Radiation Therapy

Ambient Aqueous Synthesis of Ultrasmall PEGylated Cu 2- x Se Nanoparticles as a Multifunctional Theranostic Agent for Multimodal Imaging Guided Photothermal Therapy of Cancer.

Boosting the Radiosensitizing and Photothermal Performance of Cu 2- x Se Nanocrystals for Synergetic Radiophotothermal Therapy of Orthotopic Breast Cancer.

Ultrasmall All-In-One Nanodots Formed Via Carbon Dot-Mediated and Albumin-Based Synthesis: Multimodal Imaging-Guided and Mild Laser-Enhanced Cancer Therapy.

Ultrasmall Semimetal Nanoparticles of Bismuth for Dual-Modal Computed Tomography/Photoacoustic Imaging and Synergistic Thermoradiotherapy

Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging

Degradable and Excretable Ultrasmall Transition Metal Selenide Nanodots for High‐Performance Computed Tomography Bioimaging‐Guided Photonic Tumor Nanomedicine in NIR‐II Biowindow

Ambient Aqueous Synthesis of Ultrasmall Ni0.85Se Nanoparticles for Noninvasive Photoacoustic Imaging and Combined Photothermal-Chemotherapy of Cancer

Ultrasmall Magnetic CuFeSe2 Ternary Nanocrystals for Multimodal Imaging Guided Photothermal Therapy of Cancer.

Synthesis of BSA‐Coated BiOI@Bi2S3 Semiconductor Heterojunction Nanoparticles and Their Applications for Radio/Photodynamic/Photothermal Synergistic Therapy of Tumor

FeSe<sub>2</sub>-Decorated Bi<sub>2</sub>Se<sub>3</sub>Nanosheets Fabricated via Cation Exchange for Chelator-Free<sup>64</sup>Cu-Labeling and Multimodal Image-Guided Photothermal-Radiation Therapy

Decorated Ultrathin Bismuth Selenide Nanosheets As Targeted Theranostic Agents for in Vivo Imaging Guided Cancer Radiation Therapy

BSA‐Mediated Synthesis of Bismuth Sulfide Nanotheranostic Agents for Tumor Multimodal Imaging and Thermoradiotherapy

Biomineralized Enzyme-Like Cobalt Sulfide Nanodots for Synergetic Phototherapy with Tumor Multimodal Imaging Navigation